List view / Grid view

James Yao

 

news

Novartis gains FDA approval for Afinitor®

Novartis announced today that the FDA approved Afinitor® (everolimus) tablets…

5 May 2011 | By Novartis

Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...